Dabigatran etexilate Terminated Phase 2 Trials for Nonvalvular Atrial Fibrillation / Strokes Prevention

IndicationsStatusPurposePhase
TerminatedPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT00157248Long-term, Open-label Follow-up Treatment of Patients With A-fib Who Have Been Previously Treated With BIBR 1048